Drug
Leo 158968
Leo 158968: highest development phase Phase 1, developed by LEO Pharma. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- LEO Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| LEO 158968 NCT06444867 | Phase 1 | Joint Pain |
| LEO 158968 NCT05682352 | Phase 1 |
Latest
No recent events.
Follow Leo 158968 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.